Teleflex Incorporated (TFX) Stake Decreased by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System lessened its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 5.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,400 shares of the medical technology company’s stock after selling 600 shares during the period. Louisiana State Employees Retirement System’s holdings in Teleflex were worth $2,837,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also added to or reduced their stakes in TFX. Teachers Advisors LLC raised its holdings in shares of Teleflex by 8.2% during the second quarter. Teachers Advisors LLC now owns 51,393 shares of the medical technology company’s stock valued at $10,677,000 after buying an additional 3,875 shares during the last quarter. Amalgamated Bank raised its holdings in shares of Teleflex by 27.8% during the second quarter. Amalgamated Bank now owns 8,885 shares of the medical technology company’s stock valued at $1,846,000 after buying an additional 1,934 shares during the last quarter. Stevens Capital Management LP raised its holdings in shares of Teleflex by 82.1% during the second quarter. Stevens Capital Management LP now owns 10,107 shares of the medical technology company’s stock valued at $2,100,000 after buying an additional 4,556 shares during the last quarter. PNC Financial Services Group Inc. raised its holdings in shares of Teleflex by 1.0% during the second quarter. PNC Financial Services Group Inc. now owns 23,740 shares of the medical technology company’s stock valued at $4,934,000 after buying an additional 231 shares during the last quarter. Finally, New York State Common Retirement Fund raised its holdings in shares of Teleflex by 5.1% during the second quarter. New York State Common Retirement Fund now owns 110,577 shares of the medical technology company’s stock valued at $22,973,000 after buying an additional 5,386 shares during the last quarter. 89.29% of the stock is currently owned by institutional investors.

Shares of Teleflex Incorporated (NYSE:TFX) opened at $262.93 on Wednesday. Teleflex Incorporated has a twelve month low of $162.79 and a twelve month high of $271.23. The company has a market capitalization of $11,856.07, a P/E ratio of 47.98, a P/E/G ratio of 1.94 and a beta of 1.09. The company has a current ratio of 4.72, a quick ratio of 3.70 and a debt-to-equity ratio of 0.88.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, November 2nd. The medical technology company reported $2.12 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.01 by $0.11. Teleflex had a return on equity of 16.27% and a net margin of 12.41%. The firm had revenue of $534.70 million for the quarter, compared to analysts’ expectations of $522.94 million. During the same quarter in the previous year, the company earned $1.80 earnings per share. The firm’s quarterly revenue was up 17.3% compared to the same quarter last year. analysts expect that Teleflex Incorporated will post 8.36 EPS for the current year.

A number of equities research analysts have recently weighed in on TFX shares. Stephens reaffirmed a “buy” rating and set a $270.00 price target (up previously from $230.00) on shares of Teleflex in a report on Monday, September 25th. Zacks Investment Research raised Teleflex from a “hold” rating to a “buy” rating and set a $265.00 price target on the stock in a report on Friday, September 22nd. Jefferies Group lifted their price target on Teleflex from $270.00 to $295.00 and gave the company a “buy” rating in a report on Friday, November 3rd. Needham & Company LLC lifted their price target on Teleflex from $237.00 to $285.00 and gave the company a “buy” rating in a report on Friday, November 3rd. Finally, Morgan Stanley lifted their price target on Teleflex from $274.00 to $290.00 and gave the company an “equal weight” rating in a report on Friday, November 3rd. One analyst has rated the stock with a sell rating, five have issued a hold rating and six have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $274.44.

In other Teleflex news, CEO Benson Smith sold 2,000 shares of Teleflex stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $258.10, for a total value of $516,200.00. Following the transaction, the chief executive officer now owns 76,634 shares in the company, valued at $19,779,235.40. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Stephen K. M.D. Klasko sold 200 shares of Teleflex stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $237.18, for a total transaction of $47,436.00. Following the completion of the transaction, the director now owns 8,080 shares in the company, valued at approximately $1,916,414.40. The disclosure for this sale can be found here. In the last three months, insiders have sold 2,600 shares of company stock worth $666,492. 2.39% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: “Teleflex Incorporated (TFX) Stake Decreased by Louisiana State Employees Retirement System” was reported by Week Herald and is the property of of Week Herald. If you are accessing this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The original version of this article can be accessed at https://weekherald.com/2018/01/17/teleflex-incorporated-tfx-stake-decreased-by-louisiana-state-employees-retirement-system.html.

Teleflex Company Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply